Compound ID | 215
Class: RnpA inhibitor
| Spectrum of activity: | Gram-positive |
| Details of activity: | Staphylococcus aureus |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA |
| Year first mentioned: | 2011 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|